Whisk’s AI-Powered Culinary Coach Named as Winner of Ascensia Diabetes Challenge
BASEL, Switzerland and ORLANDO, Florida, June 22, 2018 /PRNewswire/ — Today, at the American Diabetes Association’s 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care has revealed that UK-based Whisk…
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
TAIPEI, Taiwan, June 22, 2018 /PRNewswire/ — PharmaEngine Inc. (TWO: 4162) and its corporate partner, Nanobiotix S.A. (Euronext: NANO) announced today that PEP503 (NBTXR3) in combination with radiotherapy met the…
APAC Biotech and Diakonos Sign Technology Transfer and Licensing Agreement to Bring New Immunotherapy Technology to India
HOUSTON, June 22, 2018 /PRNewswire/ — India-Based APAC Biotech and US-Based Diakonos Research sign a first-of-its-kind technology transfer and licensing agreement to bring new immunotherapy technology to India as an…
TOT BIOPHARM’s 16,000L-capacity monoclonal antibodies production base put into operation
Improving the quality of life for cancer patients worldwide with innovative science and technology SUZHOU, China, June 20, 2018 /PRNewswire/ — Chinese bio-pharmaceutical developer, manufacturer and marketer of oncology drugs…
JCI-CRHG Academy of Hospital Management Named Exclusive Provider of JCI Advisory Services in the People’s Republic of China
Academy to Provide Accreditation Technical Assistance, Preparation, Resources and Training OAK BROOK, Illinois, June 21, 2018 /PRNewswire/ — Joint Commission International (JCI) and China Resources Healthcare Group Ltd. (CRHG) have…
Luye Pharma Bolsters Its Global Analgesics Portfolio with China Class 1.1 New Compound LY03012 to Start Phase I Clinical Trials
SHANGHAI, June 19, 2018 /PRNewswire/ — June 19, 2018, Luye Pharma Group announced that clinical applications of the company’s new compound candidate, extended release tablets (”LY03012”), a China Class 1.1…
Tongji University Joins Merck’s CRISPR Core Partnership Program
– With membership, Tongji University to get exclusive access to Merck’s genome-editing technology, comprehensive technical support– University joins a network of 70 CRISPR core labs around the world SHANGHAI, June…
Hebron Technology Co., Ltd. Exhibited at ACHEMA
WENZHOU, China, June 18, 2018 /PRNewswire/ — Hebron Technology Co., Ltd. (“Hebron” or the “Company”) (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in…
Insilico Medicine Earns Accolades from Frost & Sullivan for Its Pioneering R&D in AI for Aging Research and Drug Discovery
The company has leveraged its expertise in Artificial Intelligence, Big Data analytics, and blockchain to create an ecosystem of cutting-edge solutions to support R&D for aging-related products and solutions LONDON,…
Hebron Technology Co., Ltd. Announces Plan to Expand Healthcare Industry Solutions
WENZHOU, China, June 12, 2018 /PRNewswire/ — Hebron Technology Co., Ltd. (“Hebron” or the “Company”) (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in…
